Dr Ester Orlandi has more than 20 years’ experience in radiation oncology in Head & Neck cancer. 

She currently is type-B Researcher at the University of Pavia and holds the positions as Chief of the Clinical Department at CNAO. She is focused in managing rare tumors, particularly in the H&N, and is skilled in advanced radiotherapy techniques, side effects modelling, and personalized therapy. She focuses on testing new combinations of beam qualities and drugs to improve cancer treatment effectiveness. 

She is involved in several Italian and international clinical trials and registries as PI or subinvestigator.

Since March 2020 up to today, she is a representative of the EORTC H&N group for the Radiation Oncology Scientific Council (ROSC). Since January 2021 she is ESMO faculty member for the Head and Neck Cancer group and since December 2022 is Scientific Committee member for ESMO 2024. Since April 2019 up to today she is Consilour of the Italian Association of Head and Neck Oncology (AIOCC). She has been appointed as the senior scientific advisor at Shanghai Proton and Heavy Ion Center (SPHIC) .She is the author and coauthor of 7 book chapters, 229 scientific journal articles  impacted peer review journals. H-index 30.